The potential for greater success in treating devastating CNS diseases like Glioblastoma has long been severely limited. The primary hurdle is the persistent inability to effectively and directly deliver therapeutic agents to the brain, a challenge that has historically prevented many promising treatments from reaching their full potential.

Our proprietary approaches and patented technologies are delivering new therapies for brain cancers. We also facilitate the transport of established and new therapeutics across the blood-brain barrier, significantly improving their efficacy for treating a wide range of brain diseases.

By regulating tumor cell growth and providing a powerful transport mechanism for therapeutics, we plan to equip doctors and healthcare professionals with the tools to deliver significantly better outcomes for their patients.